Neoplasma · 2019 · 23 citations · 34 references
MedicineCardiologyEndocrinologyAdolescent HealthClinical EpidemiologyPediatric EndocrinologyCardiovascular DiseaseHypertension In ChildrenInsulin ResistanceLipid DisordersPediatric LymphomasAtherosclerosis RiskAtherosclerotic Plaque CharacterizationAtherosclerotic ProgressionAtherosclerotic Risk AssessmentCardiovascular Late EffectsInsulin Resistance AssessmentLipid Risk AssessmentLong-term Cardiovascular Sequelae
Long-term survivors of Hodgkin lymphoma during childhood or adolescence (HL survivors) are at high risk of developing treatment-related late cardiovascular sequelae. In our study we evaluated the presence of modifiable cardiovascular risk factors (hypertension, hyperlipoproteinemia, hyperinsulinemia, obesity), endothelial and inflammatory markers (E-selectin, PAI-1, hs-CRP) and atherosclerotic changes in the common carotid arteries. Assessment was performed in 80 young adult Hodgkin lymphoma long-term survivors at more than 10 years after the potentially cardiovascular toxic anticancer treatment (median age at evaluation 34.7 years; range 24.1-40.9 years). The HL survivors were compared with 83 age- and gender-matched healthy volunteers. The HL survivors showed unfavorable lipid profiles compared to those of healthy controls: triglycerides (p=0.01), total cholesterol (p=0.0004), low density lipoprotein cholesterol (p=0.005). In HL survivors, we found a higher prevalence of hypertension (p=0.004) and insulin resistance - HOMA-IR (p=0.0002). Ultrasonographic examination of both common carotid arteries revealed a higher prevalence of atherosclerotic plaques (p=0.0009) and higher carotid intima-media thickness (p<0.0001) in HL survivors. Markers of oxidative stress (advanced oxidation protein products, oxidized low-density lipoprotein), inflammation (hs-CRP) and endothelial dysfunction (E-selectin, PAI-1) were also higher in HL survivors (p<0.0001, p=0.0002, p=0.0031, p=0.0087, p=0.004, respectively). Adult survivors of Hodgkin lymphoma during childhood and adolescence need closer follow-up with screening of metabolic syndrome components, unfavorable lifestyle factors and early management of these risk factors.
34
Subclinical Hypothyroidism and the Risk of Coronary Heart Disease and Mortality
Nicolas Rodondi, Wendy P. J. den Elzen, Douglas C. Bauer et al. · JAMA · 2010 · 1.2K citations · Full text
Medicine, Cardiology, Endocrinology +16
Lifetime Risks of Cardiovascular Disease
Jarett D. Berry, Alan R. Dyer, Xuan Cai et al. · New England Journal of Medicine · 2012 · 930 citations · Full text
Public Health, Cardiology, Aging +12
Carotid-Wall Intima–Media Thickness and Cardiovascular Events
Joseph F. Polak, Michael Pencina, Karol M. Pencina et al. · New England Journal of Medicine · 2011 · 813 citations · Full text
Medicine, Cardiology, Epidemiology +14